{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:36:58Z","timestamp":1787841418536,"version":"build-2784847793"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s00105-010-2124-3","type":"journal-article","created":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T13:00:28Z","timestamp":1304427628000},"page":"389-402","source":"Crossref","is-referenced-by-count":8,"title":["Autoinflammatorische Syndrome\/Fiebersyndrome","Autoinflammatory syndromes\/fever syndromes"],"prefix":"10.1007","volume":"62","author":[{"given":"J.","family":"Schedel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.B.","family":"K\u00fcmmerle-Deschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"K\u00f6tter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,5]]},"reference":[{"key":"2124_CR1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11882-008-0047-1","volume":"8","author":"Glaser","year":"2008","unstructured":"Glaser RL, Goldbach-Mansky R (2008) The spectrum of monogenic autoinflammatory syndromes: understanding disease mechanisms and use of targeted therapies. Curr Allergy Asthma Rep 8:288\u2013298","journal-title":"Curr Allergy Asthma Rep"},{"key":"2124_CR2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-2007-963268","volume":"32","author":"Lohse","year":"2007","unstructured":"Lohse P (2007) Autoinflammatorische (Fieber-)Syndrome \u2013 Klinik, Genetik und Therapie. Akt Rheumatol 32:154\u2013161","journal-title":"Akt Rheumatol"},{"key":"2124_CR3","first-page":"567","volume":"22","author":"Henderson","year":"2010","unstructured":"Henderson C, Goldbach-Mansky R (2010) Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis. Curr Opin Rheumatol 22:567\u2013578","journal-title":"Curr Opin Rheumatol"},{"key":"2124_CR4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.berh.2008.08.009","volume":"22","author":"Touitou","year":"2008","unstructured":"Touitou I, Kone-Paut I (2008) Autoinflammatory diseases. Best Pract Res Clin Rheumatol 22:811\u2013829","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2124_CR5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/art.20033","volume":"50","author":"Hawkins","year":"2004","unstructured":"Hawkins PN, Lachmann HJ, Aganna E, McDermott MF (2004) Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 50:607\u2013612","journal-title":"Arthritis Rheum"},{"key":"2124_CR6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00281-007-0079-y","volume":"29","author":"Martinon","year":"2007","unstructured":"Martinon F, Gaide O, Petrilli V et al (2007) NALP inflammasomes: a central role in innate immunity. Semin Immunopathol 29:213\u2013229","journal-title":"Semin Immunopathol"},{"key":"2124_CR7","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1056\/NEJMcibr063500","volume":"355","author":"Drenth","year":"2006","unstructured":"Drenth JP, van der Meer JW (2006) The inflammasome \u2013 a linebacker of innate defense. N Engl J Med 355:730\u2013732","journal-title":"N Engl J Med"},{"key":"2124_CR8","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/art.22938","volume":"56","author":"Pope","year":"2007","unstructured":"Pope RM, Tschopp J (2007) The role of interleukin-1 and the inflammasome in gout: implications for therapy. Arthritis Rheum 56:3183\u20133188","journal-title":"Arthritis Rheum"},{"key":"2124_CR9","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood-2003-07-2531","volume":"103","author":"Neven","year":"2004","unstructured":"Neven B, Callebaut I, Prieur AM et al (2004) Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA\/NOMID, MWS, and FCU. Blood 103:2809\u20132815","journal-title":"Blood"},{"key":"2124_CR10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ncprheum0874","volume":"4","author":"Neven","year":"2008","unstructured":"Neven B, Prieur AM, Quartier dit Maire P (2008) Cryopyrinopathies: update on pathogenesis and treatment. Nat Clin Pract Rheumatol 4:481\u2013489","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2124_CR11","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1073\/pnas.0602081103","volume":"103","author":"Chae","year":"2006","unstructured":"Chae JJ, Wood G, Masters SL et al (2006) The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci U S A 103:9982\u20139987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2124_CR12","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1182\/blood-2008-01-134932","volume":"112","author":"Chae","year":"2008","unstructured":"Chae JJ, Wood G, Richard K et al (2008) The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood 112:1794\u20131803","journal-title":"Blood"},{"key":"2124_CR13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/gte.2008.0009","volume":"12","author":"Solak","year":"2008","unstructured":"Solak M, Yildiz H, Koken R et al (2008) Analysis of familial Mediterranean fever gene mutations in 202 patients with familial Mediterranean fever. Genet Test 12:341\u2013344","journal-title":"Genet Test"},{"key":"2124_CR14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1742-1241.2004.00294.x","volume":"59","author":"Sayarlioglu","year":"2005","unstructured":"Sayarlioglu M, Cefle A, Inanc M et al (2005) Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: analysis of 401 cases. Int J Clin Pract 59:202\u2013205","journal-title":"Int J Clin Pract"},{"key":"2124_CR15","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/art.1780401023","volume":"40","author":"Livneh","year":"1997","unstructured":"Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879\u20131885","journal-title":"Arthritis Rheum"},{"key":"2124_CR16","first-page":"568","volume":"26","author":"Lidar","year":"2008","unstructured":"Lidar M, Doron A, Kedem R et al (2008) Appendectomy in familial Mediterranean fever: clinical, genetic and pathological findings. Clin Exp Rheumatol 26:568\u2013573","journal-title":"Clin Exp Rheumatol"},{"key":"2124_CR17","doi-asserted-by":"crossref","unstructured":"Lachmann HJ, Sengul B, Yavuzsen TU et al (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45:746\u2013750","DOI":"10.1093\/rheumatology\/kei279"},{"key":"2124_CR18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1442-200X.2008.02554.x","volume":"50","author":"Dusunsel","year":"2008","unstructured":"Dusunsel R, Dursun I, Gunduz Z et al (2008) Genotype-phenotype correlation in children with familial Mediterranean fever in a Turkish population. Pediatr Int 50:208\u2013212","journal-title":"Pediatr Int"},{"key":"2124_CR19","doi-asserted-by":"crossref","unstructured":"van der Hilst JC, Bodar EJ, Barron KS et al (2008) Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 87:301\u2013310","DOI":"10.1097\/MD.0b013e318190cfb7"},{"key":"2124_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-1-13","volume":"1","author":"Haas","year":"2006","unstructured":"Haas D, Hoffmann GF (2006) Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis 1:13","journal-title":"Orphanet J Rare Dis"},{"key":"2124_CR21","doi-asserted-by":"crossref","unstructured":"Lainka E, Neudorf U, Lohse P et al (2009) Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristics. Rheumatology (Oxford) 48:987\u2013991","DOI":"10.1093\/rheumatology\/kep140"},{"key":"2124_CR22","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1182\/blood-2005-11-006783","volume":"108","author":"Lobito","year":"2006","unstructured":"Lobito AA, Kimberley FC, Muppidi JR et al (2006) Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood 108:1320\u20131327","journal-title":"Blood"},{"key":"2124_CR23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar2197","volume":"9","author":"Kimberley","year":"2007","unstructured":"Kimberley FC, Lobito AA, Siegel RM, Screaton GR (2007) Falling into TRAPS \u2013 receptor misfolding in the TNF receptor 1-associated periodic fever syndrome. Arthritis Res Ther 9:217","journal-title":"Arthritis Res Ther"},{"key":"2124_CR24","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1073\/pnas.0914118107","volume":"107","author":"Simon","year":"2010","unstructured":"Simon A, Park H, Maddipati R et al (2010) Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome. Proc Natl Acad Sci U S A 107:9801\u20139806","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2124_CR25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/art.24145","volume":"60","author":"Ryan","year":"2009","unstructured":"Ryan JG, Aksentijevich I (2009) Tumor necrosis factor receptor-associated periodic syndrome: toward a molecular understanding of the systemic autoinflammatory diseases. Arthritis Rheum 60:8\u201311","journal-title":"Arthritis Rheum"},{"key":"2124_CR26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/bor.0000174210.78449.6b","volume":"17","author":"Stojanov","year":"2005","unstructured":"Stojanov S, Kastner DL (2005) Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 17:586\u2013599","journal-title":"Curr Opin Rheumatol"},{"key":"2124_CR27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-3476(98)70263-X","volume":"133","author":"Blau","year":"1998","unstructured":"Blau EB (1998) Autosomal dominant granulomatous disease of childhood: the naming of things. J Pediatr 133:322\u2013323","journal-title":"J Pediatr"},{"key":"2124_CR28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-3476(85)80394-2","volume":"107","author":"Blau","year":"1985","unstructured":"Blau EB (1985) Familial granulomatous arthritis, iritis, and rash. J Pediatr 107:689\u2013693","journal-title":"J Pediatr"},{"key":"2124_CR29","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1182\/blood-2004-07-2972","volume":"105","author":"Kanazawa","year":"2005","unstructured":"Kanazawa N, Okafuji I, Kambe N et al (2005) Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105:1195\u20131197","journal-title":"Blood"},{"key":"2124_CR30","first-page":"373","volume":"32","author":"Rose","year":"2005","unstructured":"Rose CD, Doyle TM, McIlvain-Simpson G et al (2005) Blau syndrome mutation of CARD15\/NOD2 in sporadic early onset granulomatous arthritis. J Rheumatol 32:373\u2013375","journal-title":"J Rheumatol"},{"key":"2124_CR31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.24134","volume":"60","author":"Okafuji","year":"2009","unstructured":"Okafuji I, Nishikomori R, Kanazawa N et al (2009) Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum 60:242\u2013250","journal-title":"Arthritis Rheum"},{"key":"2124_CR32","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.2135380100","volume":"100","author":"Shoham","year":"2003","unstructured":"Shoham NG, Centola M, Mansfield E et al (2003) Pyrin binds the PSTPIP1\/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A 100:13501\u201313506","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2124_CR33","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","volume":"360","author":"Aksentijevich","year":"2009","unstructured":"Aksentijevich I, Masters SL, Ferguson PJ et al (2009) An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 360:2426\u20132437","journal-title":"N Engl J Med"},{"key":"2124_CR34","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMoa0809568","volume":"360","author":"Reddy","year":"2009","unstructured":"Reddy S, Jia S, Geoffrey R et al (2009) An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N Engl J Med 360:2438\u20132444","journal-title":"N Engl J Med"},{"key":"2124_CR35","first-page":"358","volume":"10","author":"Padeh","year":"2008","unstructured":"Padeh S, Stoffman N, Berkun Y (2008) Periodic fever accompanied by aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA syndrome) in adults. Isr Med Assoc J 10:358\u2013360","journal-title":"Isr Med Assoc J"},{"key":"2124_CR36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.pcl.2005.01.005","volume":"52","author":"Padeh","year":"2005","unstructured":"Padeh S (2005) Periodic fever syndromes. Pediatr Clin North Am 52:577\u2013609, vii","journal-title":"Pediatr Clin North Am"},{"key":"2124_CR37","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1610-0387.2008.06627.x","volume":"6","author":"Eiling","year":"2008","unstructured":"Eiling E, Schroder JO, Gross WL et al (2008) The Schnitzler syndrome: chronic urticaria and monoclonal gammopathy \u2013 an autoinflammatory syndrome? J Dtsch Dermatol Ges 6:626\u2013631","journal-title":"J Dtsch Dermatol Ges"},{"key":"2124_CR38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00003495-200868030-00005","volume":"68","author":"Kontzias","year":"2008","unstructured":"Kontzias A, Efthimiou P (2008) Adult-onset Still\u2019s disease: pathogenesis, clinical manifestations and therapeutic advances. Drugs 68:319\u2013337","journal-title":"Drugs"},{"key":"2124_CR39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semarthrit.2007.04.002","volume":"37","author":"Kotter","year":"2007","unstructured":"Kotter I, Wacker A, Koch S et al (2007) Anakinra in patients with treatment-resistant adult-onset Still\u2019s disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum 37:189\u2013197","journal-title":"Semin Arthritis Rheum"},{"key":"2124_CR40","doi-asserted-by":"crossref","unstructured":"Fautrel B, Zing E, Golmard JL et al (2002) Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore) 81:194\u2013200","DOI":"10.1097\/00005792-200205000-00003"},{"key":"2124_CR41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1568010053622894","volume":"4","author":"Gul","year":"2005","unstructured":"Gul A (2005) Behcet\u2019s disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4:81\u201383","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"2124_CR42","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/ard.2006.068841","volume":"66","author":"Kone-Paut","year":"2007","unstructured":"Kone-Paut I, Sanchez E, Le Quellec A et al (2007) Autoinflammatory gene mutations in Behcet\u2019s disease. Ann Rheum Dis 66:832\u2013834","journal-title":"Ann Rheum Dis"},{"key":"2124_CR43","first-page":"S1","volume":"23","author":"Yazici","year":"2005","unstructured":"Yazici H, Fresko I (2005) Behcet\u2019s disease and other autoinflammatory conditions: What\u2019s in a name? Clin Exp Rheumatol 23:S1\u2013S2","journal-title":"Clin Exp Rheumatol"},{"key":"2124_CR44","first-page":"98","volume":"32","author":"Melikoglu","year":"2005","unstructured":"Melikoglu M, Fresko I, Mat C et al (2005) Short-term trial of etanercept in Behcet\u2019s disease: a double blind, placebo controlled study. J Rheumatol 32:98\u2013105","journal-title":"J Rheumatol"},{"key":"2124_CR45","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","volume":"33","author":"Kotter","year":"2004","unstructured":"Kotter I, Gunaydin I, Zierhut M, Stubiger N (2004) The use of interferon alpha in Behcet disease: review of the literature. Semin Arthritis Rheum 33:320\u2013335","journal-title":"Semin Arthritis Rheum"},{"key":"2124_CR46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7326\/0003-4819-149-4-200808190-00018","volume":"149","author":"Botsios","year":"2008","unstructured":"Botsios C, Sfriso P, Furlan A et al (2008) Resistant Behcet disease responsive to anakinra. Ann Intern Med 149:284\u2013286","journal-title":"Ann Intern Med"},{"key":"2124_CR47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"Martinon","year":"2006","unstructured":"Martinon F, Petrilli V, Mayor A et al (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237\u2013241","journal-title":"Nature"},{"key":"2124_CR48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature04946","volume":"442","author":"Meylan","year":"2006","unstructured":"Meylan E, Tschopp J, Karin M (2006) Intracellular pattern recognition receptors in the host response. Nature 442:39\u201344","journal-title":"Nature"},{"key":"2124_CR49","doi-asserted-by":"crossref","unstructured":"Catalano-Pons C, Comte A, Wipff J et al (2008) Clinical outcome in children with chronic recurrent multifocal osteomyelitis. Rheumatology (Oxford) 47:1397\u20131399","DOI":"10.1093\/rheumatology\/ken249"},{"key":"2124_CR50","first-page":"776","volume":"5","author":"O","year":"2004","unstructured":"O\u2019Neill LA (2004) How NOD-ing off leads to Crohn disease. Nat Immunol 5:776\u2013778","journal-title":"Nat Immunol"},{"key":"2124_CR51","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00018-008-7502-y","volume":"65","author":"Rosenstiel","year":"2008","unstructured":"Rosenstiel P, Jacobs G, Till A, Schreiber S (2008) NOD-like receptors: ancient sentinels of the innate immune system. Cell Mol Life Sci 65:1361\u20131377","journal-title":"Cell Mol Life Sci"},{"key":"2124_CR52","first-page":"691","volume":"45","author":"Ruther","year":"1998","unstructured":"Ruther U, Nunnensiek C, Muller HA et al (1998) Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn\u2019s disease). Hepatogastroenterology 45:691\u2013699","journal-title":"Hepatogastroenterology"},{"key":"2124_CR53","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa0907206","volume":"361","author":"Glocker","year":"2009","unstructured":"Glocker EO, Kotlarz D, Boztug K et al (2009) Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 361:2033\u20132045","journal-title":"N Engl J Med"},{"key":"2124_CR54","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.23474","volume":"58","author":"Gattorno","year":"2008","unstructured":"Gattorno M, Sormani MP, D\u2019Osualdo A et al (2008) A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum 58:1823\u20131832","journal-title":"Arthritis Rheum"},{"key":"2124_CR55","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/archderm.142.12.1591","volume":"142","author":"Leslie","year":"2006","unstructured":"Leslie KS, Lachmann HJ, Bruning E et al (2006) Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1\/NALP3 mutations. Arch Dermatol 142:1591\u20131597","journal-title":"Arch Dermatol"},{"key":"2124_CR56","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","volume":"58","author":"Hoffman","year":"2008","unstructured":"Hoffman HM, Throne ML, Amar NJ et al (2008) Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum 58:2443\u20132452","journal-title":"Arthritis Rheum"},{"key":"2124_CR57","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","volume":"360","author":"Lachmann","year":"2009","unstructured":"Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB et al (2009) Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 360:2416\u20132425","journal-title":"N Engl J Med"},{"key":"2124_CR58","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJM197410312911804","volume":"291","author":"Dinarello","year":"1974","unstructured":"Dinarello CA, Wolff SM, Goldfinger SE et al (1974) Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med 291:934\u2013937","journal-title":"N Engl J Med"},{"key":"2124_CR59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0049-0172(91)90019-V","volume":"20","author":"Ben-Chetrit","year":"1991","unstructured":"Ben-Chetrit E, Levy M (1991) Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years. Semin Arthritis Rheum 20:241\u2013246","journal-title":"Semin Arthritis Rheum"},{"key":"2124_CR60","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jbspin.2008.08.004","volume":"76","author":"Fonnesu","year":"2008","unstructured":"Fonnesu C, Cerquaglia C, Giovinale M et al (2008) Familial Mediterranean fever: a review for clinical management. Joint Bone Spine 76:227\u2013233","journal-title":"Joint Bone Spine"},{"key":"2124_CR61","first-page":"489","volume":"66","author":"Mitroulis","year":"2008","unstructured":"Mitroulis I, Papadopoulos VP, Konstantinidis T, Ritis K (2008) Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient. Neth J Med 66:489\u2013491","journal-title":"Neth J Med"},{"key":"2124_CR62","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jbspin.2008.04.001","volume":"75","author":"Roldan","year":"2008","unstructured":"Roldan R, Ruiz AM, Miranda MD, Collantes E (2008) Anakinra: new therapeutic approach in children with familial Mediterranean fever resistant to colchicine. Joint Bone Spine 75:504\u2013505","journal-title":"Joint Bone Spine"},{"key":"2124_CR63","first-page":"1362","volume":"35","author":"Tweezer-Zaks","year":"2008","unstructured":"Tweezer-Zaks N, Rabinovich E et al (2008) Interferon-alpha as a treatment modality for colchicine- resistant familial Mediterranean fever. J Rheumatol 35:1362\u20131365","journal-title":"J Rheumatol"},{"key":"2124_CR64","first-page":"S41","volume":"22","author":"Calguneri","year":"2004","unstructured":"Calguneri M, Apras S, Ozbalkan Z et al (2004) The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients. Clin Exp Rheumatol 22:S41\u2013S44","journal-title":"Clin Exp Rheumatol"},{"key":"2124_CR65","first-page":"S37","volume":"22","author":"Tunca","year":"2004","unstructured":"Tunca M, Akar S, Soyturk M et al (2004) The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: a double-blind, placebo-controlled trial. Clin Exp Rheumatol 22:S37\u2013S40","journal-title":"Clin Exp Rheumatol"},{"key":"2124_CR66","first-page":"435","volume":"24","author":"Sakallioglu","year":"2006","unstructured":"Sakallioglu O, Duzova A, Ozen S (2006) Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever. Clin Exp Rheumatol 24:435\u2013437","journal-title":"Clin Exp Rheumatol"},{"key":"2124_CR67","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.rhu.0000128856.13595.eb","volume":"10","author":"Metyas","year":"2004","unstructured":"Metyas S, Arkfeld DG, Forrester DM, Ehresmann GR (2004) Infliximab treatment of familial mediterranean fever and its effect on secondary AA amyloidosis. J Clin Rheumatol 10:134\u2013137","journal-title":"J Clin Rheumatol"},{"key":"2124_CR68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00296-006-0164-x","volume":"27","author":"Rigante","year":"2006","unstructured":"Rigante D, Ansuini V, Bertoni B et al (2006) Treatment with anakinra in the hyperimmunoglobulinemia D\/periodic fever syndrome. Rheumatol Int 27:97\u2013100","journal-title":"Rheumatol Int"},{"key":"2124_CR69","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clpt.2004.01.012","volume":"75","author":"Simon","year":"2004","unstructured":"Simon A, Drewe E, van der Meer JW et al (2004) Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 75:476\u2013483","journal-title":"Clin Pharmacol Ther"},{"key":"2124_CR70","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.11218","volume":"48","author":"Takada","year":"2003","unstructured":"Takada K, Aksentijevich I, Mahadevan V et al (2003) Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 48:2645\u20132651","journal-title":"Arthritis Rheum"},{"key":"2124_CR71","doi-asserted-by":"crossref","unstructured":"Drewe E, Huggins ML, Morgan AG et al (2004) Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology (Oxford) 43:1405\u20131408","DOI":"10.1093\/rheumatology\/keh357"},{"key":"2124_CR72","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM200010053431412","volume":"343","author":"Drewe","year":"2000","unstructured":"Drewe E, McDermott EM, Powell RJ (2000) Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome. N Engl J Med 343:1044\u20131045","journal-title":"N Engl J Med"},{"key":"2124_CR73","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/art.23475","volume":"58","author":"Gattorno","year":"2008","unstructured":"Gattorno M, Pelagatti MA, Meini A et al (2008) Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 58:1516\u20131520","journal-title":"Arthritis Rheum"},{"key":"2124_CR74","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1600-0463.2006.apm_522.x","volume":"114","author":"Milman","year":"2006","unstructured":"Milman N, Andersen CB, Hansen A et al (2006) Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation. Apmis 114:912\u2013919","journal-title":"Apmis"},{"key":"2124_CR75","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1002\/art.22966","volume":"56","author":"Arostegui","year":"2007","unstructured":"Arostegui JI, Arnal C, Merino R et al (2007) NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum 56:3805\u20133813","journal-title":"Arthritis Rheum"},{"key":"2124_CR76","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/art.25035","volume":"62","author":"Yasui","year":"2010","unstructured":"Yasui K, Yashiro M, Tsuge M et al (2010) Thalidomide dramatically improves the symptoms of early-onset sarcoidosis\/Blau syndrome: its possible action and mechanism. Arthritis Rheum 62:250\u2013257","journal-title":"Arthritis Rheum"},{"key":"2124_CR77","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jpeds.2004.08.001","volume":"145","author":"Cortis","year":"2004","unstructured":"Cortis E, De Benedetti F, Insalaco A et al (2004) Abnormal production of tumor necrosis factor (TNF)-alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome. J Pediatr 145:851\u2013855","journal-title":"J Pediatr"},{"key":"2124_CR78","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","volume":"161","author":"Brenner","year":"2009","unstructured":"Brenner M, Ruzicka T, Plewig G et al (2009) Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol 161:1199\u20131201","journal-title":"Br J Dermatol"},{"key":"2124_CR79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0929-693X(00)88918-6","volume":"7","author":"Pillet","year":"2000","unstructured":"Pillet P, Ansoborlo S, Carrere A et al (2000) (P)FAPA syndrome: value of cimetidine. Arch Pediatr 7:54\u201357","journal-title":"Arch Pediatr"},{"key":"2124_CR80","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1651-2227.2008.00837.x","volume":"97","author":"Tasher","year":"2008","unstructured":"Tasher D, Stein M, Dalal I, Somekh E (2008) Colchicine prophylaxis for frequent periodic fever, aphthous stomatitis, pharyngitis and adenitis episodes. Acta Paediatr 97:1090\u20131092","journal-title":"Acta Paediatr"},{"key":"2124_CR81","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/adc.86.6.434","volume":"86","author":"Galanakis","year":"2002","unstructured":"Galanakis E, Papadakis CE, Giannoussi E et al (2002) PFAPA syndrome in children evaluated for tonsillectomy. Arch Dis Child 86:434\u2013435","journal-title":"Arch Dis Child"},{"key":"2124_CR82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semarthrit.2007.04.001","volume":"37","author":"Koning","year":"2007","unstructured":"Koning HD de, Bodar EJ, Meer JW van der, Simon A (2007) Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 37:137\u2013148","journal-title":"Semin Arthritis Rheum"},{"key":"2124_CR83","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1365-2133.2007.07799.x","volume":"156","author":"Ramadan","year":"2007","unstructured":"Ramadan KM, Eswedi HA, El-Agnaf MR (2007) Schnitzler syndrome: a case report of successful treatment using the anti-CD20 monoclonal antibody rituximab. Br J Dermatol 156:1072\u20131074","journal-title":"Br J Dermatol"},{"key":"2124_CR84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000063143","volume":"205","author":"Lipsker","year":"2002","unstructured":"Lipsker D (2002) The Schnitzler syndrome \u2013 a treatment at last? Dermatology 205:1\u20132","journal-title":"Dermatology"},{"key":"2124_CR85","first-page":"707","volume":"35","author":"Gleeson","year":"2008","unstructured":"Gleeson H, Wiltshire E, Briody J et al (2008) Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape. J Rheumatol 35:707\u2013712","journal-title":"J Rheumatol"},{"key":"2124_CR86","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ncprheum0681","volume":"4","author":"Church","year":"2008","unstructured":"Church LD, Cook GP, McDermott MF (2008) Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol 4:34\u201342","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2124_CR87","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.bor.0000198006.65697.5b","volume":"18","author":"Samuels","year":"2006","unstructured":"Samuels J, Ozen S (2006) Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 18:108\u2013117","journal-title":"Curr Opin Rheumatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-010-2124-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-010-2124-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-010-2124-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T09:30:44Z","timestamp":1560159044000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-010-2124-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["2124"],"URL":"https:\/\/doi.org\/10.1007\/s00105-010-2124-3","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}